DIABIO — Diagonal Bio AB Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- SEK6.54m
- SEK4.80m
- SEK0.06m
Brief: Diagonal Bio Gets Conditional Approval For Listing On NGM Nordic SME
Brief: Diagonal Bio Applies For Change Of Marketplace To NGM Nordic SME
Brief: Diagonal Bio Resolves On Directed Issue Of Units To All External Underwriters
Brief: Diagonal Bio Says Positive Pilot Test Results, Gets Order From Stallzet
Brief: Diagonal Bio Announces Partnership With Kolgjini Stables
Brief: Diagonal Bio Announces That It Is Exploring Financing Options
Brief: Diagonal Bio Q3 Operating Loss Narrows To SEK 1.2 Mln
Brief: Diagonal Bio Announces Successful External Validation Of Lamplify For Viruses In Pigs
Brief: Diagonal Bio Announces Successful External Validation Of Lamplify
Brief: Diagonal Bio Q2 Operating Loss Widens To SEK 3.1 Mln
Brief: Diagonal Bio Gets Order From Technical University Of Denmark
Brief: Diagonal Bio Appoints Fata Mrsic New CFO
Brief: Diagonal Bio Announces New Collaboration With Löberöds Hästklinik
Brief: Diagonal Bio To Get Proceeds Of About SEK 18 Mln Through Completed Rights Issue
Brief: Diagonal Bio Announces Successful Pilot Study Results, Extended Partnership With Hørsholm Veterinary Clinic
Brief: Diagonal Bio Says Appointed Karin Wehlin As New CEO
Brief: Diagonal Bio Says Board Decides On Preferential Rights Issue Of Units
Brief: Diagonal Bio AB Says Qtrly Net Sales Amounted To 23 KSEK
Brief: Diagonal Signs Distribution Agreement With Techtum Lab